Journal of the Endocrine Society · 2018 · 37 citations · 22 references
MedicineEndocrinologySurgeryCardiothoracic SurgeryEndocrine SurgeryHemodynamic ManagementAdrenal DisordersAdrenal EndocrinologyAdrenal SurgeryClinical Outcome MeasurementOutcome MeasuresPrimary Hyperaldosteronism SurgeryStandardized Outcome Definitions
OBJECTIVES: The aim of this study was to investigate the impact of adrenal venous sampling (AVS) lateralization cutoffs on surgical outcomes. PATIENTS AND METHODS: Cosyntropin-stimulated AVS was used to guide surgical management of 377 patients with primary aldosteronism (PA) who were evaluated 6 months after surgery. MAIN OUTCOME MEASURES: The proportion of patients that achieved clinical benefit and complete biochemical success based on the AVS aldosterone lateralization index (LI) was determined. RESULTS: = 0.024 for trend). After adjustment for confounders and using those patients with an LI between 2 and 4 as a reference, a clinical benefit was associated only with those with an LI > 10 (OR, 2.30; 95% CI, 1.03 to 5.16), whereas complete biochemical success was associated with those with an LI between 4 and 10 (OR, 2.83; 95% CI, 1.14 to 7.01) or LI > 10 (OR, 3.55; 95% CI, 1.47 to 8.55). CONCLUSIONS: Difference of clinical outcome was relatively small when strict LI diagnostic threshold was used; biochemical cure was sufficiently achieved when an LI > 4 was used. Our study by standardized outcome measures validated that an LI > 4 may be appropriate for determining unilateral disease in PA.
22
John W. Funder, Robert M. Carey, Franco Mantero et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 2.9K citations · Full text
Tracy Ann Williams, Jacques W.M. Lenders, Paolo Mulatero et al. · The Lancet Diabetes & Endocrinology · 2017 · 945 citations · Full text
Medicine, Endocrinology, Surgery +14